Promising future..., page-9

My opinion.......I have been in Primabiomed for a good 5-6 years, chasing rainbows, as we all are.....
In chronological terms PRR is an old company that could be argued as being a capital killer,
hard to argue with that but me being the neverending optimistist will have a crack at it......
The acquisition of immutep (itself an old company) is a masterstroke in my opinion, given the
field they are involved in and indeed have been involved for quite some time has all of a sudden
been propelled into the forefront of the biotech sector....
So I have reappraised my opinion of Prima to that of being a young company without having
to convince the market to invest in it to fund initial research........
Good buy from Prima and good luck to everyone, our time is coming and I wish everyone
the very best.....